266 related articles for article (PubMed ID: 34536465)
21. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
22. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.
Shin JY; Kim JH; Yu YS; Khwarg SI; Choung HK; Shin HY; Ahn HS
Korean J Ophthalmol; 2010 Aug; 24(4):219-24. PubMed ID: 20714385
[TBL] [Abstract][Full Text] [Related]
23. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
24. Presentation of retinoblastoma patients in Malaysia.
Subramaniam S; Rahmat J; Rahman NA; Ramasamy S; Bhoo-Pathy N; Pin GP; Alagaratnam J
Asian Pac J Cancer Prev; 2014; 15(18):7863-7. PubMed ID: 25292078
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
[TBL] [Abstract][Full Text] [Related]
26. Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead.
Berman EL; Donaldson CE; Giblin M; Martin FJ
Clin Exp Ophthalmol; 2007; 35(1):5-12. PubMed ID: 17300564
[TBL] [Abstract][Full Text] [Related]
27. Changing management of retinoblastoma.
Shields CL; Shields JA
Clin Exp Ophthalmol; 2004 Aug; 32(4):345-6. PubMed ID: 15281963
[No Abstract] [Full Text] [Related]
28. Management of massive orbital involvement of intraocular retinoblastoma.
Kiratli H; Bilgiç S; Ozerdem U
Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
[TBL] [Abstract][Full Text] [Related]
29. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
30. Clinical profile, management, and outcome of retinoblastoma in singapore.
Lim FP; Soh SY; Iyer JV; Tan AM; Swati H; Quah BL
J Pediatr Ophthalmol Strabismus; 2013; 50(2):106-12. PubMed ID: 23244241
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
Shah PK; Narendran V; Kalpana N
Ophthalmic Genet; 2015; 36(3):248-50. PubMed ID: 24372404
[TBL] [Abstract][Full Text] [Related]
32. Global Retinoblastoma Treatment Outcomes: Association with National Income Level.
Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2021 May; 128(5):740-753. PubMed ID: 33007338
[TBL] [Abstract][Full Text] [Related]
33. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
34. Ocular and orbital complications following the treatment of retinoblastoma.
Anteby I; Ramu N; Gradstein L; Miskin H; Pe'er J; Benezra D
Eur J Ophthalmol; 1998; 8(2):106-11. PubMed ID: 9673480
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
[TBL] [Abstract][Full Text] [Related]
36. Globe salvage treatment in group D and group E retinoblastoma.
Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
[No Abstract] [Full Text] [Related]
37. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
38. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
39. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
40. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review.
Weng PY; Chen SH; Kao LY; Tsai YJ; Yang SH; Tseng CK; Tsay PK; Jaing TH
Medicine (Baltimore); 2020 Sep; 99(38):e22201. PubMed ID: 32957352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
